| Literature DB >> 33681643 |
Najib Kissani1,2, Oussama Cherkaoui Rhazouani1, Zouhayr Souirti3,4, Mounia Khramaz1, Chettati Meryem1, Yassine Mebrouk5, Reda Ouazzani6.
Abstract
The World Health Organization (WHO) estimates that about 50 million people of all ages have epilepsy and nearly 85% of whom live in low- and middle-income (LMICs) countries. In Morocco, epilepsy is one of the major neurological health conditions, with an estimated prevalence of 1.1%. The management of patients is difficult due to multiple factors. The lack of neurologists whose number is currently 180, the uneven distribution of neurologists who are concentrated in large cities, 43% of whom are in Rabat and Casablanca alone; the low involvement of general practitioners in the management of epilepsy; the frequent consultation of traditional healers; and the low coverage of social security all contribute to the treatment gap. The management of epilepsy has advanced considerably since the early nineties. Several factors contributed to this progress: the increasing number of neurologists compared to previous years, the creation of well-equipped new academic centers, and small units of general neurology, in addition to the disuse of several antiepileptic drugs. However, much work remains to be done against the use of many forms of traditional practices and the low involvement of general practitioners in the management of epilepsy. This is the first study on epilepsy conducted in Morocco.Entities:
Keywords: antiepileptic drugs; community; geographical distribution; neurosurgery; traditional practices
Mesh:
Substances:
Year: 2020 PMID: 33681643 PMCID: PMC7918313 DOI: 10.1002/epi4.12440
Source DB: PubMed Journal: Epilepsia Open ISSN: 2470-9239
Figure 1Map of the geographical distribution of neurologists in Morocco: a/b/c. a: Teaching university hospitals, b: public sector, c: private sector
Figure 2A member of our team doing an itinerary consultation at Ouarzazate (200 km south of Marrakech)
Figure 3Location of the region of Ouarzazate, place of visiting clinics
Figure 4Pie chart showing traditional practices of epilepsy in Casablanca and Marrakech
Percentage of traditional practices prior to medical visit
| Countries | Percentage of traditional practices prior to medical visit | |
|---|---|---|
| Nigeria | 47.6% | |
| Morocco | Casablanca | 66.4% |
| Marrakech | 60% | |
| Ouarzazate | 63.8% | |
Antiepileptic drugs available in Morocco
| The classic antiepileptic drugs | |
| Carbamazepine | Tegretol®, Crizepine®, Zeptol®, Alepsia®, Carbamazepine Normon®. |
| Phenobarbital | Gardenal® |
| Sodium valproate | Depakine®, Micropakine®, Encorate® |
| New antiepileptic drugs | |
| Gabapentin | Neurontin®, Gabamax®, Nupentin®. |
| Lamotrigine | Lamotrigine®, Synnax®. |
| Oxcarbazepine | Trileptal® |
| Levetiracetam | Keppra® |
| Topiramate | Topiramate GT® |